Compact Mass Spectrometer Improves Analysis - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Compact Mass Spectrometer Improves Analysis


Pharmaceutical Technology
Volume 38, Issue 3, pp. 14

Advion released its latest compact mass spectrometer (CMS), the expression S. The new CMS includes polarity switching during a single analysis to ensure detection of a range of compounds, fast mass scanning (10,000 u/s) for compatibility with UPLC, SFC, and where multiple compounds need to be monitored simultaneously with SIM, as well as higher flow rates of 1-2 mL/min for simpler interfacing with standard chromatographic conditions. The expression S replaces the first generation expression CMS, which will remain available for Advion’s OEM partners. In addition to the hardware advancements, a number of new software features offer additional analysis and data processing options. The software also provides compatibility with DataApex Clarity chromatography software providing seamless integrations with many LC platforms.

Advion

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here